MHRA approves guselkumab for Crohn’s disease and ulcerative colitis

19th May 2025 Uncategorised 0

Regulator confirms safety and efficacy of new treatment option for patient

More: MHRA approves guselkumab for Crohn’s disease and ulcerative colitis
Source: News